Author

R. L. Ferris

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. R. Cillo· 2 shared C. Lampenfeld· 2 shared T. C. Bruno· 2 shared A. Chang· 1 shared A. Kulkarni· 1 shared A. L. Szymczak-Workman· 1 shared A. Liu· 1 shared A. Somasundaram· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. R. Cillo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Expression of Tim-3 drives naive Treg to an effector-like state with enhanced suppressive activity

H. Banerjee, H. Nieves-Rosado, A. Kulkarni, B. Murter, U. R. Chandran, A. Chang, A. L. Szymczak-Workman, L. Vujanovic, R. L. Ferris, L. P. Kane

The paper shows that Tim-3 expression in Treg cells drives them to an effector-like state with enhanced suppressive activity, promoting tumor growth.

bioRxiv · Jul 31, 2020 · PreprintImmunology

Divergent cancer etiologies drive distinct B cell signatures and tertiary lymphoid structures

A. T. Ruffin, A. R. Cillo, T. Tabib, A. Liu, S. Onkar, S. Kunning, C. Lampenfeld, I. Abecassis, Z. Qi, R. Soose, U. D. Duvvuri, S. Kim, S. Oesterreich, R. Lafyatis, R. L. Ferris, , T. C. Bruno

This study identifies distinct B cell signatures and tertiary lymphoid structures in HPV+ and HPV- HNSCC, highlighting their role in antitumor immunity.

bioRxiv · May 29, 2020 · PreprintImmunology

Systemic immune dysfunction in cancer patients driven by IL6 and IL8 induction of an inhibitory receptor module in peripheral CD8+ T cells

A. Somasundaram, A. R. Cillo, C. Lampenfeld, L. Oliveri, M. A. Velez, S. Joyce, M. J. Calderon, R. Dadey, D. Rajasundaram, D. P. Normolle, S. C. Watkins, J. G. Herman, J. M. Kirkwood, E. J. Lipson, R. L. Ferris, , D. A. A. Vignali

This study identifies a systemic immune dysfunction in cancer patients driven by IL6 and IL8, leading to CD8+ T cell dysfunction and poor prognosis.

bioRxiv · May 6, 2020 · PreprintCancer Biology